---
granola_id: d75ad6e9-7d87-4cbe-a3fe-f75503595752
title: "Alex Debayo-Doherty and Virtue"
type: note
created: 2025-11-06T17:29:53.049Z
updated: 2025-11-07T18:02:10.594Z
attendees:
  - adebayodoherty@insightpartners.com
  - sd@virtuevc.com
---
### Meeting Setup & Brief Introductions

- Called meeting to connect Virtue team with Alex Debayo-Doherty from Insight Partners
- Alex had scheduling conflict, rescheduled to 3:30 Eastern same day
- Brief introductions completed before rescheduling
	- Alex: 4.5 years at Insight, focuses on data infrastructure, AI/ML, vertical applications
	- Series A/B investor, firm does Series A through growth
	- Personal connection through Shub (met Jeff Horing last week)

### Virtue Fund Overview

- Healthcare/life sciences focused, everything except pure therapeutics
- Zero-to-one stage focus, almost always first money in
- Fund details:
	- Second fund active, $100M+ under management across two funds
	- Check sizes: $500K to $2-3M upfront, strong follow-on capacity
	- 80% lead deals, flexible on control/runway deals
- Investment thesis: Healthcare investing was too myopic in prior decade
	- Opportunities extend beyond managed care and care delivery
	- Focus on compliance, privacy, data utilization infrastructure

### Integral Investment Context

- Virtue led Shubâ€™s pre-seed, participated in seed (Haystack/GP co-led)
- Company focus: compliance and privacy agents for healthcare data
- Addresses rush of new healthcare data coming to market
- Key question: How to utilize data compliantly before monetizing/licensing

### Michael Spiro

- [Note from meeting]

### Next Steps

- Rescheduled call for 3:30 Eastern same day with Alex joining
- Emre to join first 15 minutes (has 3:45 meeting conflict)
- Sean and Alex to continue full discussion

Chat with meeting transcript: https://notes.granola.ai/d/d75ad6e9-7d87-4cbe-a3fe-f75503595752
